Related Experiment Video
Updated: May 28, 2026
03:38
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Holistic Management of Pulmonary Fibrosis: A Comprehensive Review
Inés Palacio1, Fernanda Hernández-González1, Jacobo Sellarés1
1Pulmonology Department, Hospital Clinic, 08402 Barcelona, Spain.
Medicina (Kaunas, Lithuania)
|May 27, 2026
Summary
Managing pulmonary fibrosis requires a holistic, patient-centered strategy beyond antifibrotic drugs. Integrating comprehensive care improves patient quality of life and well-being.
Area of Science:
- Pulmonology
- Internal Medicine
Background:
- Pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and progressive fibrosing interstitial lung diseases (PF-ILDs), presents significant morbidity and mortality.
- Current disease-centered management with antifibrotic therapies is insufficient for addressing patients' complex needs.
Purpose of the Study:
- To advocate for a holistic, patient-centered approach in managing pulmonary fibrosis.
- To review evidence supporting integrated care dimensions and identify implementation barriers.
Main Methods:
- Comprehensive literature review of holistic care components for pulmonary fibrosis.
- Analysis of barriers to implementing integrated care models.
- Exploration of future perspectives including precision medicine.
Main Results:
- Holistic care integrates pharmacological treatment with comorbidity assessment, pulmonary rehabilitation, psychosocial support, nutritional optimization, palliative care, social support, and digital health.
- Barriers include healthcare fragmentation, lack of multidisciplinary protocols, and resource limitations.
Conclusions:
- A shift towards comprehensive, multidisciplinary care models is essential for improving outcomes and quality of life in patients with fibrosing ILDs.
- Future strategies should focus on precision medicine and integrated care to enhance patient well-being.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.